Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2026Journal of Medical EconomicsOpen Access

Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18–64 years in Switzerland using PCV21

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMuloongo SimuzingiliZYZinan YiAFAndrea Favre-Bulle

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Simuzingili et al. (2026) studied this question.

synapsesocial.com/papers/6aa92c45e6a6728514255550https://doi.org/10.1080/13696998.2026.2726640
View Full Paper
Ask AI
Bookmark
Share